Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 4, 2007, Pages 274-279

  Rami, L ^a   Gomez Anson B ^a,b   Bosch, B ^a   Sanchez Valle R ^a   Monte, G C ^a,b   Villar, A ^a   Molinuevo, J L ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alzheimer's disease; Cognitive tests; Magnetic resonance imaging; Memory; Mild cognitive impairment

Indexed keywords

CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; MAJOR CLINICAL STUDY; MEMORY; NERVE DEGENERATION; PRIORITY JOURNAL; SCREENING TEST; SPECTROSCOPY; VERBAL MEMORY;

AGED; ALZHEIMER DISEASE; AMNESIA; ASPARTIC ACID; CEREBRAL CORTEX; COGNITION DISORDERS; CREATINE; FEMALE; GYRUS CINGULI; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY; PARIETAL LOBE; PROTONS; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 34748866043     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107487     Document Type: Article

References (17)

1. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
2. Valenzuela M, Sachdev P: Magnetic resonance spectroscopy in AD. Neurology 2001;56:592-598.
3. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC: Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000;55:210-217.
4. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP: Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005;384:23-28.
5. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
6. 1H MRS study of probable Alzheimer's disease and normal aging: implication for longitudinal monitoring of dementia progression. Magn Reson Imaging 1999;17:291-299.
7. 1H MRS magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 2002;8:934-942.
8. Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y: Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol 2002;59:955-962.
9. Waldman AD, Rai GS: The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology 2003;45:507-512.
10. Peña-Casanova J, Guardia J, Bertran-Serra I, Manero RM, Jarne A: Shortened version of the Barcelona test (I): subtests and normal profiles. Neurologia 1997;12:99-111.
11. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
12. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I: Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
13. Rami L, Molinuevo JL, Sanchez-Valle R, Bosch B, Villar A: Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population. Int J Geriatr Psychiatry 2007;22:294-304.
14. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672.
15. Hodges JR, Patterson K: Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia, 1995;33:441-459.
16. Salvan AM, Ceccaldi M, Confort-Gouny S, Milandre C, Cozzone PJ, Vion-Dury J: Correlation between cognitive status and cerebral inositol in Alzheimer-type dementia. J Neurol 1998;245:686-688.
17. Jessen F, Block W, Träber F, Keller E, Flacke S, Papassotiropoulus A, Lamerichs R, Heun R, Schild HH: Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000;55:684-688.